Long Road Ahead
Qualify for a free subscription to HealthLeaders magazine.
There may be some hope for those looking for a more rapid boost in the healthcare sector, or at least part of it. A June analysis by Forbes and CIT found that for middle-market healthcare companies—for-profit hospitals, group practices, medical device makers with annual revenues between $25 million and $1 billion—60% of executives surveyed expected revenue to grow in the next year. More than 40% of those survey respondents also expected their capital expenditures to increase within the year.
Another factor in the length of the healthcare downturn may be gauging the effect of the stimulus package. While the IT provisions will start pumping the HITECH Act's $19 billion in funding into hospitals and health plans in 2010, some have charged that the ARRA's provisions meant to fund state Medicaid programs—and by extension the hospitals waiting to be paid—were circumvented by states for other uses.
And the unknown factor with the largest potential to accelerate a healthcare recovery remains the health reform debate in Washington, with the possible impact of a public health plan or other mechanisms of expanded access that could speed the end of the healthcare downturn.
"We have had 13 recessions since the 1940s," Keckley says, "and nothing parallels this. This is no-man's land. We've never been here before."
Jim Molpus is editor-in-chief for HealthLeaders Media. He can be contacted at firstname.lastname@example.org.
- Ebola: Health Officials Try to Quell Front Line Fears
- Reducing Readmissions Starts with Better Collaboration
- Ebola: A New Normal in Dallas
- Readmissions: No Quick Fix to Costly Hospital Challenge
- Partners HealthCare M&A Deal Under Scrutiny
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- Defensive Medicine Still Prevalent Despite Tort Reform
- Health Literacy Month Gets a Boost from Payers
- Debate Over Consolidation's Effect On Cost Rages On
- How Educated Nurses Save Money